Pharma Reverse Pitch at BIO 2026

​On the margins of BIO 2026, Invest Québec International and CQDM are organizing a curated reverse pitch session bringing together leading pharmaceutical companies and life sciences innovators.

​In this interactive format, participating pharma partners will present their strategic priorities, R&D focus areas, and collaboration needs, followed by networking with companies aligned with these interests.

​The objective is to foster meaningful connections and accelerate partnership opportunities in areas such as drug development, AI-enabled discovery, and advanced therapeutics.

​Please note that attendance is subject to approval.

​About CDQM: CQDM is a pharma-based consortium active in biopharmaceutical research. Our mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy.